Clinical Trial Update: Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating sleep-maintenance activity of three doses of SKP-1041 in adults with primary insomnia. The trial has completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• SKP-1041

Snippet

Sponsor: Somnus Therapeutics, Inc. | Conditions: Sleep Disorder, Primary Insomnia | Phase 2 | Status: COMPLETED | Results posted: 2013-02-01